Caixin
Company Index
BeiGene
BeiGene
NEWS
company-info
Hiring Ernst & Young in the U.S. may help but won’t work without a bilateral Sino-American accord on audit documents
Apr.8 2022 04:59 AM
company-info
With listing on STAR Market, loss-making cancer-drug developer would be the first Chinese biotech to trade shares on the mainland and in Hong Kong and New York
Nov.17 2021 05:11 AM
company-info
Eleven-year-old cancer-focused Chinese biotech turned its first profit this year after three of its drugs made China’s National Reimbursement Drug List
Jun.29 2021 06:18 AM
company-info
Beijing-based BeiGene will take over commercialization of three cancer medicines from American biopharmaceutical giant in China as part of deal, and work to commercialize 20 more
Nov.1 2019 18:25 PM
company-info
Top 15 listings by Chinese firms have raised $28.7 billion so far this year, led by China Tower this week
Aug.10 2018 17:18 PM
company-info
After lackluster BeiGene IPO, analysts argue share prices will rise when more products hit market
Aug.8 2018 18:45 PM
company-info
Hong Kong IPO could raise nearly $1 billion, complementing drug developer’s current Nasdaq listing
Jul.30 2018 18:47 PM
company-info
U.S. biopharmaceutical firm plans to hold 5.9% of cancer-drug developer to market new treatments in Europe and America
Jul.7 2017 18:44 PM